Iceland· IS-EU/1/03/253/001-003
Aldurazyme
A enzymes product containing laronidasum inn, registered in Iceland by Genzyme Europe B.V.. The same ATC class is registered in 3 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Laronidasum inn is registered in 3 of 19 countries.
Countries holding a registration under ATC A16AB (enzymes), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 2 of them publish a price we can compare per daily dose
Laronidasum inn · ATC A16AB
3 / 19 countries
- Czechiaprice
- Icelandprice
- Ireland
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Laronidasum INN
- Manufacturer
- Genzyme Europe B.V.
- Country
- Iceland (IS)
- ATC code
- A16AB
- ATC class
- Enzymes
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Laronidasum inn in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALDURAZYMESanofi B.V., Amsterdam
- United StatesALDURAZYMEGenzyme Corporation
- FinlandAldurazymeOrifarm Oy
- FranceALDURAZYME 100 U/ml, solution à diluer pour perfusionSANOFI (PAYS-BAS)
- United KingdomAldurazyme 500units/5ml concentrate for solution for infusion vialsSanofi
- BelgiumAldurazyme 100 U/mlSanofi
- Japanラロニダーゼ（遺伝子組換え）サノフィ
- NetherlandsAldurazyme, concentraat voor oplossing voor i.v. infusie, 100U/ml, 5 mlGenzyme Europe BV
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Aldurazyme
- Norway · Aldurazyme
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3ff853b-dc80-4bc7-aeff-5f1a5c2ceaec GET /v1/drugs/d3ff853b-dc80-4bc7-aeff-5f1a5c2ceaec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Innrennslisþykkni, lausn",
"source": "lyfjastofnun",
"atc_raw": "A16AB",
"marketed": false,
"strength": "100 U ml",
"ma_number": "EU/1/03/253/001-003",
"substance": "Laronidasum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "37823"
}See everything about laronidasum inn.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.